Satya Prakash serves as the Director of the Biomedical Technology and Cell Therapy Research Laboratory and a Professor of biomedical engineering, artificial cells and organs research, physiology, and experimental medicine at the Faculty of Medicine, McGill University, Montreal, Quebec, Canada. He has published more than 225 peer-reviewed articles/abstracts, been listed as an inventor in 45 approved/pending patents, edited 2 books, and contributed 18 book chapters presenting more than 80 invited talks across the globe. He is the winner of 28 awards including “Medial for Outstanding Contribution to the Advancement of Science,” Overseas Scholar, Fraser, Monat and McPherson Award, FRSQ Chercheure-Boursière Award, and the Canadian Institute of Health Research (CIHR) Investigator Award. At McGill, he has trained more than 50 graduate students, visiting scholars, postdoctoral fellows, undergraduate, and fellows. Currently, his team conducts major research in the areas of probiotics, microencapsulation, nanoencapsulation, artificial cells, drug targeting, siRNA, cell delivery, nanomedicine, kidney substitutes, colon cancer, fatty liver, breast cancer, diabetes, stent design, wound healing, and other human health and technology developments. He serves as a Regional Editor (Americas), Assistant Editor, and on the editorial board of various journals, and he serves to various panels including CIHR, Ontario Advance Health Technology, Alberta Ingenuity, and other panels. He holds a B.S. (H), M.S., M.Tech., Ph.D., and D.S. degrees. He has been the Cofounder of Micropharma and serves as the Director.
Biography Updated on 8 April 2012